• Yin Li, Lianyun Wu, Yanhong Yong, Xueting Niu, Yuan Gao, Qiu Zhou, Huili Xie, Xiaoxi Liu, Youquan Li, Zhichao Yu, A M Abd El-Aty, and Xianghong Ju.
• Department of Veterinary Medicine, College of Coastal Agricultural Sciences, Guangdong Ocean University, Zhanjiang, China; Marine Medical Research and Development Centre, Shenzheng Institute of Guangdong Ocean University, Shenzheng, China.
• Nutrition. 2024 Mar 19; 124: 112428112428.

ObjectivesThis study aimed to explore the protective mechanism of chitosan oligosaccharide (COS) against lipopolysaccharide (LPS)-induced inflammatory responses in IEC-6 cells and dextran sodium sulfate (DSS)-induced colitis in mice.MethodsThe cell inflammation model was constructed by LPS in vitro and enteritis model by DSS in vivo.ResultsFollowing LPS exposure, IEC-6 cell proliferation significantly decreased, epithelial cell integrity was compromised, and TNF-α and IL-1β levels were increased. However, COS pretreatment reversed these changes. In vivo, DSS-treated mice exhibited evident pathological alterations, including heightened inflammatory levels and significantly decreased expression of tight junction proteins and critical proteins in the Mitogen activated proteins kinase signaling pathway. Nevertheless, COS administration notably reduced inflammatory levels and increased the expression of tight junction proteins and key proteins in the Mitogen activated proteins kinase signaling pathway.ConclusionsOur findings suggest that COS safeguards gut barrier integrity by upregulating tight junction proteins through the ERK1/2 signaling pathway. Therefore, COS has emerged as a promising candidate for novel drug interventions against inflammatory bowel disease.Copyright © 2024 Elsevier Inc. All rights reserved.

5 keywords...

hide…